Company:Tempus (business)
 | |
| Industry | Biotechnology |
|---|---|
| Founded | 2015 |
| Founder | Eric Lefkofsky (CEO) |
| Headquarters | Chicago, Illinois |
| Website | www.tempus.com |
Tempus is a technology company focused on collecting and analyzing large volumes of molecular and clinical data. In the interest of furthering precision medicine, Tempus built a series of data pipelines to collect, cleanse, and analyze data, at scale.[1] Tempus was co-founded by Eric Lefkofsky and Brad Keywell in Chicago, Illinois in 2015. Lefkofsky has cited the experience of a loved one being treated for cancer as the impetus for starting the company.[2][3]
Business
Tempus has announced collaborations with hospitals such as Cleveland Clinic,[4] Duke University School of Medicine,[5] Mayo Clinic,[6] Northwestern’s Lurie Cancer Center,[7] Penn’s Abramson Cancer Center,[8] University of Chicago Medicine,[9] University of Michigan[10] and community hospitals across the country.
Financing
On September 25, 2017 Tempus announced that it had raised $130M to date after closing a $70M, Series C, round of venture funding co-led by New Enterprise Associates (NEA), a firm started by Frank Bonsal, Dick Kramlich, and Chuck Newhall, and Revolution Growth, a firm started by Steve Case, Donn Davis and Ted Leonsis. Tempus has been valued at $700 million.[11]
References
- ↑ Preston, J. (2017, July 07). Why Groupon's cofounder is diving head first into healthcare. Retrieved September 27, 2017, from https://medcitynews.com/2017/07/why-groupons-cofounder-diving-into-healthcare/
- ↑ Dallke, J. (2017, June 26). Eric Lefkofsky’s Self-Funded Mission to Cure Cancer Through Data. Retrieved September 26, 2017, from https://www.americaninno.com/chicago/eric-lefkofskys-self-funded-mission-to-cure-cancer-through-data
- ↑ Pletz, J. (2016, October 01). Can Eric Lefkofsky save your life? Retrieved September 26, 2017, from http://www.chicagobusiness.com/article/20161001/ISSUE01/310019995/can-eric-lefkofsky-save-your-life
- ↑ (2017, September 14). Tempus Partners With Cleveland Clinic on Precision Cancer Rx Study. Retrieved September 27, 2017, from https://www.genomeweb.com/informatics/tempus-partners-cleveland-clinic-precision-cancer-rx-study
- ↑ Tempus Teams with Major Academic Medical Center to Advance Treatment Options for Patients Diagnosed with Aggressive Brain Cancer. (2017, March 02). Retrieved September 27, 2017, from https://finance.yahoo.com/news/tempus-teams-major-academic-medical-140000956.html
- ↑ Graham, M. (2017, January 04). Groupon co-founder's cancer-fighting startup Tempus partners with Mayo Clinic. Retrieved September 26, 2017, from http://www.chicagotribune.com/bluesky/originals/ct-lefkofsky-tempus-mayo-clinic-bsi-20170104-story.html
- ↑ Pletz, J. (2016, September 29). Lefkofsky startup takes on cancer. Retrieved September 27, 2017, from http://www.chicagobusiness.com/article/20160929/BLOGS11/160929779/lefkofsky-startup-takes-on-cancer
- ↑ Penn Medicine’s Abramson Cancer Center Launches Initiative to Improve & Personalize BRCA Mutations. (2017, April 28). Retrieved September 27, 2017, from http://hitconsultant.net/2017/04/28/penn-medicines-abramson-cancer-center-initiative/
- ↑ (2017, June 22). Tempus, University of Chicago Medicine Partner on Pancreatic Cancer Study. Retrieved September 27, 2017, from https://www.genomeweb.com/informatics/tempus-university-chicago-medicine-partner-pancreatic-cancer-study
- ↑ Cohen, J. K. (2017, June 13). University of Michigan to use AI, bioinformatics for personalized breast cancer care. Retrieved September 27, 2017, from https://www.beckershospitalreview.com/healthcare-information-technology/university-of-michigan-to-use-ai-bioinformatics-for-personalized-breast-cancer-care.html
- ↑ Tindera, M. (2017, September 25). Groupon Cofounder's New Healthcare Startup Raises $70 Million In Latest Funding Round. Retrieved September 26, 2017, from https://www.forbes.com/sites/michelatindera/2017/09/25/groupon-cofounders-new-healthcare-startup-raises-70-million-in-latest-funding-round/#383c24433126
External links
 |
